General
Showing 2193–2208 of 2225 results
-
Article: Validation of a ready to use Clauss fibrinogen
€3.03 Only for registered clients -
Article: Value and implications of the anti-Xa activity monitoring in pregnant women receiving prophylactic LMWH: a retrospective study
€3.03 Only for registered clients -
Article: Vascular safety profile of new generation BCR-ABL tyrosine kinase inhibitors in the treatment of chronic myeloid leukaemia
€3.03 Only for registered clients -
Article: Venetoclax-Azacitidine, the new standard of care for AML patients unfit for intensive treatment: A guide for clinical practice
€3.03 Only for registered clients -
Article: Venetoclax-rituximab induces deep responses in relapsed CLL
€3.03 Only for registered clients -
Article: Venetoclax, the first available bcl-2 antagonist for chronic lymphocytic leukaemia
€3.03 Only for registered clients -
Article: Venetoclax, the first available bcl-2 antagonist for chronic lymphocytic leukaemia
€3.03 Only for registered clients -
Article: VENOUS THROMBOEMBOLISM
€3.03 Only for registered clients -
Article: VEXAS Syndrome: Current knowledge and management strategies
€3.03 Only for registered clients -
Article: VEXAS-syndrome: A state of the art
€3.03 Only for registered clients -
Article: Volume 6, Issue 1, February 2012
€3.03 Only for registered clients -
Article: Von Willebrand factor and ADAMTS13: new players in ischemia/reperfusion injury
€3.03 Only for registered clients -
Article: VON WILLEBRAND FACTOR: A NEW FLOW MARKER IN CARDIOVASCULAR PATHOLOGY
€3.03 Only for registered clients -
Article: Waldenstrom’s macroglobulinaemia: Belgian Hematology Society guidelines
€3.03 Only for registered clients -
Article: What about oligometastatic therapy in prostate cancer?
€3.03 Only for registered clients -
Article: What about oligometastatic therapy in prostate cancer?
€3.03 Only for registered clients